AbbVie reports loss as COVID-19 hits Botox sales – Reuters

AbbVie reports loss as COVID-19 hits Botox sales – Reuters

Drugmaker AbbVie Inc reported a loss in the second quarter on Friday, as comparable sales from wrinkle treatment Botox, acquired as part of its $63 billion Allergan Plc deal, slumped due to the impact of the COVID-19 pandemic.

Read More…

You May Also Like